CS First Boston Cuts Merck to Hold from Buy
Shares of Merck & Co. (MRK ) fell after CS First Boston downgraded the drug company to hold from buy. During intraday trading on Tuesday, Merck forecasted 2002 EPS growth to be at same level as in 2001.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.